TCM
ODT
Tang Capital Management’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-12,767,435
| Closed | -$17.2M | – | 58 |
|
|
2021
Q4 | $17.2M | Sell |
12,767,435
-2,747,131
| -18% | -$3.71M | 3.47% | 7 |
|
|
2021
Q3 | $45.1M | Hold |
15,514,566
| – | – | 9.37% | 4 |
|
|
2021
Q2 | $54.1M | Hold |
15,514,566
| – | – | 10.78% | 4 |
|
|
2021
Q1 | $53.1M | Hold |
15,514,566
| – | – | 14.93% | 4 |
|
|
2020
Q4 | $298M | Buy |
15,514,566
+275,784
| +2% | +$5.3M | 45.48% | 1 |
|
|
2020
Q3 | $205M | Buy |
15,238,782
+1,163,513
| +8% | +$15.6M | 37.03% | 1 |
|
|
2020
Q2 | $596M | Hold |
14,075,269
| – | – | 57.94% | 1 |
|
|
2020
Q1 | $389M | Hold |
14,075,269
| – | – | 54.57% | 1 |
|
|
2019
Q4 | $457M | Hold |
14,075,269
| – | – | 54.57% | 1 |
|
|
2019
Q3 | $366M | Hold |
14,075,269
| – | – | 62.68% | 1 |
|
|
2019
Q2 | $516M | Buy |
14,075,269
+989,231
| +8% | +$36.3M | 69.79% | 1 |
|
|
2019
Q1 | $289M | Sell |
13,086,038
-961,212
| -7% | -$21.3M | 53.31% | 1 |
|
|
2018
Q4 | $198M | Buy |
14,047,250
+250,503
| +2% | +$3.53M | 45.38% | 1 |
|
|
2018
Q3 | $268M | Buy |
13,796,747
+1,384,409
| +11% | +$26.9M | 43.72% | 1 |
|
|
2018
Q2 | $274M | Hold |
12,412,338
| – | – | 34.74% | 2 |
|
|
2018
Q1 | $263M | Buy |
12,412,338
+210,000
| +2% | +$4.45M | 38.64% | 1 |
|
|
2017
Q4 | $305M | Buy |
+12,202,338
| New | +$305M | 48.33% | 1 |
|